XML 58 R14.htm IDEA: XBRL DOCUMENT
v2.4.1.9

8. STOCK INCENTIVE PLAN | 12 Months Ended
--- | ---
Dec. 31, 2014
Equity [Abstract] |
NOTE 8. STOCK INCENTIVE PLAN | The Company has a stock incentive plan, originally created in 1992, most recently amended in 2001. No additional grants may be made under the plan. All stock options have an exercise price that is equal to the fair market value of the Company’s stock on the date the options were granted. Administration of the plan, including determination of the number, term, and type of options granted, resides with the Board of Directors or a duly authorized committee of the Board of Directors. Options were generally granted based on employee performance with vesting periods ranging from date of grant to seven years. At the date of the grant, the maximum term before expiration is ten years. The following table presents information on stock options outstanding for the periods shown:
|  | 2014 |  |  | 2013 |
|  | Weighted Average Exercise |  |  | Weighted Average Exercise |
|  | Shares |  |  | Price |  |  | Shares |  |  | Price |
Outstanding at beginning of period |  |  | 260,200 |  |  | $ | 3.82 |  |  |  | 311,200 |  |  | $ | 3.76 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (37,229 | ) |  |  | 3.99 |  |  |  | (51,000 | ) |  |  | 3.48 |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at end of period |  |  | 222,971 |  |  | $ | 3.79 |  |  |  | 260,200 |  |  | $ | 3.82 |
The following table presents information on stock options outstanding for the periods shown:
|  | 2014 |  |  | 2013 |
Intrinsic value of options exercised in the period |  | $ | 64,383 |  |  | $ | 92,952 |
Stock options fully vested and expected to vest |  |  | 222,971 |  |  |  | 260,200 |
Weighted average exercise price |  | $ | 3.79 |  |  | $ | 3.82 |
Aggregate intrinsic value |  | $ | 447,611 |  |  | $ | 642,548 |
Weighted average contractual term of options |  | 1.64 years |  |  | 2.47 years |
Stock options vested and currently exercisable |  |  | 188,971 |  |  |  | 199,200 |
Weighted average exercise price |  | $ | 3.90 |  |  | $ | 4.01 |
Aggregate intrinsic value |  | $ | 358,561 |  |  | $ | 453,528 |
Weighted average contractual term of options |  | 1.28 years |  |  | 1.92 years |
Weighted-average options outstanding and exercisable at December 31, 2014 are as follows:
|  |  | Options Outstanding |  |  | Options Exercisable |
|  |  |  |  |  | Weighted |  |  |  |  |  |  |  |  |  |
|  |  | Number |  |  | Average |  |  | Weighted |  |  | Number |  |  | Weighted |
|  |  | Outstanding at |  |  | Remaining |  |  | Average |  |  | Exercisable at |  |  | Average |
Exercise |  |  | December 31, |  |  | Contractual |  |  | Exercise |  |  | December 31, |  |  | Exercise |
Price |  |  | 2014 |  |  | Life |  |  | Price |  |  | 2014 |  |  | Price |
| 2.99 |  |  |  | 4,000 |  |  |  | 0.12 |  |  |  | 2.99 |  |  |  | 4,000 |  |  |  | 2.99 |
| 3.09 |  |  |  | 22,971 |  |  |  | 6.56 |  |  |  | 3.09 |  |  |  | 8,971 |  |  |  | 3.09 |
| 3.24 |  |  |  | 80,000 |  |  |  | 1.55 |  |  |  | 3.24 |  |  |  | 60,000 |  |  |  | 3.24 |
| 3.76 |  |  |  | 62,000 |  |  |  | 0.58 |  |  |  | 3.76 |  |  |  | 62,000 |  |  |  | 3.76 |
| 5.00 |  |  |  | 54,000 |  |  |  | 0.99 |  |  |  | 5.00 |  |  |  | 54,000 |  |  |  | 5.00 |
$2.99 - $ 5.00 |  |  |  | 222,971 |  |  |  | 1.64 |  |  | $ | 3.79 |  |  |  | 188,971 |  |  | $ | 3.90 |
All share-based compensation is measured at the grant date based on the fair value of the award, and is recognized as an expense in earnings over the requisite service period. The fair value of each stock option granted is estimated on the date of grant using the Black-Scholes based stock option valuation model. This model uses the assumptions listed in the table below. Expected volatilities are based on implied volatilities from the Company’s stock, historical volatility of the Company’s stock, and other factors. Expected dividends are based on the Company’s plan not to pay dividends for the foreseeable future. The Company uses historical data to estimate option exercises and employee terminations within the valuation model. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. There were no stock options granted during the years ended December 31, 2014 and 2013. Stock compensation expense was $21,164 and $22,839 for the years ended December 31, 2014 and 2013, respectively, and is included in selling, general & administrative expenses on the statement of income. As of December 31, 2014, unrecognized compensation expense related to stock options was $17,409.

X
- Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References No definition available. + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration